x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Foundation Fighting Blindness

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

science

All Episodes

00:03:13

ARVO 2024 Highlight: InGel’s Cell Therapy Shows...

Foundation Fighting Blindness ·

2024/05/22

The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease

en

00:03:08

ARVO 2024 Highlight: PYC Reports Initial Clinical...

Foundation Fighting Blindness ·

2024/05/16

No serious adverse events were reported. One patient had encouraging improvement in retinal sensitivity.

en

00:04:18

ARVO 2024 Highlight: New Gene Linked to RP in People...

Foundation Fighting Blindness ·

2024/05/14

The discovery will help geneticists diagnose more RP patients with African descent.

en

00:03:10

ARVO 2024 Highlight: Positive Two-Year Results from...

Foundation Fighting Blindness ·

2024/05/10

Mutations in PDE6B are a leading cause of retinitis pigmentosa.

en

00:29:37

Eye on the Cure Podcast | Episode 65: Matthew Whitaker

Foundation Fighting Blindness ·

2024/05/03

Matthew Whitaker talks to host Ben Shaberman about his remarkable achievements and success as a young jazz pianist and composer. Matthew was born three months prematurely and weighed less than two pounds. The oxygen he needed to stay alive also caused total blindness. But now 23 years old, the renowned music prodigy has recorded four albums, received several honors and awards, and appeared on TV shows such as Showtime at the Apollo, the Today Show, Ellen, and 60 Minutes.

en

00:05:02

Atsena’s XLRS Gene Therapy Shows Efficacy in Phase...

Foundation Fighting Blindness ·

2024/05/02

The XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.

en

00:02:46

SalioGen Developing Novel Gene Insertion Therapy for...

Foundation Fighting Blindness ·

2024/04/19

The company’s innovative Gene Coding™ platform enables seamless insertion of DNA into selective genomic locations.

en

00:27:10

Eye on the Cure Podcast | Episode 64: Dr. Kapil Bharti

Foundation Fighting Blindness ·

2024/04/16

Kapil Bharti, PhD, a senior investigator and director of the Intramural Research Program at the National Eye Institute (NEI), talks with host Ben Shaberman about his clinical trial underway for an innovative cell therapy for geographic atrophy (advanced dry age-related macular degeneration) as well as a clinical trial of the drug metformin for Stargardt disease.

en

00:03:52

Phase 3 Clinical Trial of NAC Launched for RP Patients

Foundation Fighting Blindness ·

2024/04/12

The drug is thought to work independent of the mutated gene causing RP.

en

00:02:30

ViGeneron Launches Clinical Trial of Gene Therapy for...

Foundation Fighting Blindness ·

2024/04/11

The gene therapy is administered using a less-invasive intravitreal injection.

en

00:02:52

Ocugen to Launch Phase 3 Clinical Trial of Modifier...

Foundation Fighting Blindness ·

2024/04/08

The emerging treatment is designed to work independent of the patient’s mutated gene.

en

00:03:50

Nanoscope Plans to Apply for FDA Approval for its...

Foundation Fighting Blindness ·

2024/03/27

The company reported positive two-year results for its Phase 2 clinical trial of MCO-010.

en

00:02:58

Opus Reports Vision Improvements for Patients in LCA5...

Foundation Fighting Blindness ·

2024/03/26

Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial by Foundation Fighting Blindness

en

00:15:58

Eye on the Cure Podcast | Episode 63: Dr. Hema Ramkumar

Foundation Fighting Blindness ·

2024/03/08

Hema Ramkumar, MD, a retinal specialist, surgeon, and founder of the company Oculogenex, talks with host Ben Shaberman about her emerging therapy that targets mitchondria to slow the progression of intermediate dry age-related macular degeneration and potentially other retinal diseases. She also discusses her experiment that will put mice in space so researchers can gain a better understanding of retinal degeneration.

en

00:30:23

Eye on the Cure Podcast | Episode 62: Dr. Peter Quinn

Foundation Fighting Blindness ·

2024/02/23

Peter Quinn, PhD, a principal investigator and associate research scientist at Columbia University, talks to host Ben Shaberman about the promise of emerging CRISPR/Cas9 gene editing therapies, including base and prime editing approaches, for inherited retinal diseases. Dr. Quinn also reviews gene editing projects ongoing in his lab for patients with mutations in CRB1 and PRPH2.

en

00:02:02

jCyte Announces Plans to Launch Phase 3 Clinical...

Foundation Fighting Blindness ·

2024/02/21

Known as retinal progenitors, the company’s jCells® are designed to preserve photoreceptors in people with retinitis pigmentosa (RP) and other retinal diseases.

en

00:03:09

Beacon Therapeutics Reports Encouraging Interim...

Foundation Fighting Blindness ·

2024/02/09

Beacon Therapeutics has reported vision improvements for five of eight patients receiving the high dose of its X-linked retinitis pigmentosa (XLRP) gene therapy in the Phase 2 SKYLINE clinical trial. Known as AGTC-501, the emerging gene therapy is for patients with mutations in RPGR, the gene most frequently associated with XLRP. Interim, 12-month results for SKYLINE were reported on February 7, 2024, by Mark Pennesi, MD, PhD, director, Ophthalmic Genetics at the Retina Foundation of the Southwest,

en

00:24:34

Eye on the Cure Podcast | Episode 61: Dr. Jose Sahel

Foundation Fighting Blindness ·

2024/02/02

Dr. Jose Sahel, one of the most honored and accomplished leaders in the retinal disease research space, talks with host Ben Shaberman about his establishment and leadership of renowned ophthalmology clinical research centers at the University of Pittsburgh Medical Center and Institut de la Vision in Paris. They also discuss emerging inhertied retinal disease therapies from SparingVision, a biotech co-founded by Dr. Sahel.

en

00:03:29

Ascidian to Launch Clinical Trial for Stargardt...

Foundation Fighting Blindness ·

2024/02/01

ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.

en

00:40:21

Eye on the Cure Podcast | Episode 60: Justin Kauflin

Foundation Fighting Blindness ·

2024/01/19

Justin Kauflin, a renowned jazz pianist who lost his vision as a boy, talks to host Ben Shaberman about his extensive touring, numerous collaborations, and close friendship with legendary trumpeter Clark Terry. Their story was captured in the hit documentary film Keep On Keepin' On. Justin became a jazz pro at the age of 14, toured globally with Quincy Jones, and was voted jazz artist of the year by VEER magazine.

en

243 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter